Cargando…

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)

Detalles Bibliográficos
Autor principal:	Ferreira, Natália
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642000/ http://dx.doi.org/10.1186/1750-1172-10-S1-I9

Ejemplares similares

Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
por: Ferreira, Natalia, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

ATTR-FAP: liver transplantation vs oral medication, how and when
por: Erikzon, Bo Goran
Publicado: (2015)

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

Therapeutic education programme in TTR-FAP
por: Théaudin, Marie, et al.
Publicado: (2015)

Neuropathic phenotypes and natural history of FAP
por: Adams, David
Publicado: (2015)

Preimplantation genetic diagnosis for TTR-FAP in Portugal
por: Carvalho, Filipa
Publicado: (2015)

Biopsy experience in a FAP endemic area
por: Pires, Manuel Melo
Publicado: (2015)

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H.‐J., et al.
Publicado: (2016)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups
por: Rintell, David, et al.
Publicado: (2021)

Emerging CNS involvement in FAP-TTR long survival patients
por: Maia, Luisa
Publicado: (2015)

TTR-FAP: liver transplant vs oral medication. How and when
por: Coelho, Teresa
Publicado: (2015)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

When to decide to enroll a TTR-FAP patient in a Clinical Trial?
por: Buades, Juan
Publicado: (2015)

Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
por: Lipowska, Marta, et al.
Publicado: (2015)

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
por: Inês, Mónica, et al.
Publicado: (2015)

Treatment of gastrointestinal complication in transthyretin amyloidosis. A single centre’s experience
por: Suhr, Ole B
Publicado: (2015)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Clinical, epidemiological, genetic, and electrophysiological characteristics of transthyretin familial amyloid polyneuropathies in Israel
por: Sadeh, Menachem, et al.
Publicado: (2015)

Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
por: Chequer, Renata, et al.
Publicado: (2015)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan
por: Miyake, Zenshi, et al.
Publicado: (2018)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
por: Stewart, Michelle, et al.
Publicado: (2015)

Familial arthropathies
por: Al-Mayouf, Sulaiman
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_prarv1h81rpneum30c0lavslrk